By Fineline Cube 
China-based TINGSN Technology has reportedly secured RMB 100 million (USD 14 million) in a Series B+ financing round. The funding was led by Efung Capital, with participation from existing investors Qiming Venture Partners and Huangpu Pharmaceutical Industry Investment Fund.
Funding Purpose
The proceeds will be directed towards the research and development (R&D) and clinical investment of 4D intracardiac ultrasound (ICE) technology.
Company Profile
TINGSN Technology, which maintains R&D centers in both the US and China, is dedicated to technological innovation in cardiac electrophysiology and structural heart disease using ultrasound. The company stands out as the only domestic entity to have successfully developed an ASIC chip-integrated 4D ICE system, advancing it to the clinical stage.-Fineline Info & Tech